23/11/2025 16:47
EQS-Adhoc: Bayer Aktiengesellschaft: Bayer’s Asundexian Met Primary Efficacy and Safety Endpoints in Landmark Phase III OCEANIC-STROKE Study in Secondary Stroke Prevention
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd pEQSAdhoc: Bayer Aktiengesellschaft / Key words: Study resultsbr/ Bayer Aktiengesellschaft: Bayer’s Asundexian Met Primary Efficacy and Safety Endpoints in Landmark Phase III OCEANICSTROKE Study... Lire...
31/07/2025 23:15
EQS-Adhoc: Bayer Aktiengesellschaft: Bayer upgrades currency-adjusted sales and earnings guidance for 2025 and establishes additional provisions for litigation in the United States
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd pEQSAdhoc: Bayer Aktiengesellschaft / Key words: Half Year Reportbr/ Bayer Aktiengesellschaft: Bayer upgrades currencyadjusted sales and earnings guidance for 2025 and establishes additional provisions for litigation... Lire...
19/02/2024 17:23
EQS-Adhoc: Bayer Aktiengesellschaft: Bayer plans to amend its dividend policy to reduce debt
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd pEQSAdhoc: Bayer Aktiengesellschaft / Key words: Dividendbr/ Bayer Aktiengesellschaft: Bayer plans to amend its dividend policy to reduce debt br/br/ 19Feb2024 / 17:23 CET/CESTbr/ Disclosure of an inside... Lire...
19/11/2023 23:47
EQS-Adhoc: Bayer Aktiengesellschaft: OCEANIC-AF study stopped early due to lack of efficacy
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd pEQSAdhoc: Bayer Aktiengesellschaft / Key words: Study resultsbr/ Bayer Aktiengesellschaft: OCEANICAF study stopped early due to lack of efficacy br/br/ 19Nov2023 / 23:47 CET/CESTbr/ Disclosure... Lire...
24/07/2023 19:32
EQS-Adhoc: Bayer Aktiengesellschaft: Bayer lowers full-year outlook
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd pEQSAdhoc: Bayer Aktiengesellschaft / Key words: Change in Forecastbr/ Bayer Aktiengesellschaft: Bayer lowers fullyear outlook br/br/ 24Jul2023 / 19:32 CET/CESTbr/ Disclosure of an inside... Lire...
08/02/2023 17:14
EQS-Adhoc: Bayer Aktiengesellschaft: William N. Anderson to succeed Werner Baumann as Chairman of the Board of Management of Bayer AG
html xmlns=http://www.w3.org/1999/xhtmlbodytable border=trtd pEQSAdhoc: Bayer Aktiengesellschaft / Key words: Personnelbr/ Bayer Aktiengesellschaft: William N. Anderson to succeed Werner Baumann as Chairman of the Board of Management of Bayer AG br/br/ 08Feb2023 / 17:14... Lire...
27/05/2021 01:06
Bayer Aktiengesellschaft: Bayer kündigt Fünf-Punkte-Plan zum effektiven Umgang mit potenziellen künftigen Glyphosat-Klagen an
html xmlns=http://www.w3.org/1999/xhtmlbodytable border=trtd pDGAPAdhoc: Bayer Aktiengesellschaft / Schlagworte: Stellungnahme/Rechtssachebr/ Bayer Aktiengesellschaft: Bayer kündigt FünfPunktePlan zum effektiven Umgang mit potenziellen künftigen GlyphosatKlagen an... Lire...
27/05/2021 01:06
Bayer Aktiengesellschaft: Bayer announces five-point plan to effectively address potential future Roundup(TM) claims
html xmlns=http://www.w3.org/1999/xhtmlbodytable border=trtd pDGAPAdhoc: Bayer Aktiengesellschaft / Key words: Statement/Legal Matterbr/ Bayer Aktiengesellschaft: Bayer announces fivepoint plan to effectively address potential future RoundupTM claims br/br/ 27May2021 / 01:06... Lire...
30/09/2020 19:10
Bayer Aktiengesellschaft: Bayer to accelerate transformation to address challenging market environment and enable additional growth investments
DGAPAdhoc: Bayer Aktiengesellschaft / Key words: Forecast Bayer Aktiengesellschaft: Bayer to accelerate transformation to address challenging market environment and enable additional growth investments 30Sep2020 / 19:10 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the... Lire...